References:
  1. Bussmann WD, Schupp D. Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema. Am J Cardiol. 1978 May 1;41(5):931-6.
  2. Bosc E, Bertinchant JP, Hertault J. Utilisation de la trinitrine injectable (bolus de 3 mg) dans le traitement de l’oedème pulmonaire cardiogénique [The use of injectable nitroglycerin (a bolus of 3 mg) in the treatment of cardiogenic pulmonary edema]. Ann Cardiol Angeiol (Paris). 1982 Oct-Nov;31(6):477-80.
  3. Stemple K, DeWitt KM, Porter BA, Sheeser M, Blohm E, Bisanzo M. High-dose nitroglycerin infusion for the management of sympathetic crashing acute pulmonary edema (SCAPE): A case series. Am J Emerg Med. 2021 Jun;44:262-266.
  4. López-Rivera F, Cintrón Martínez HR, Castillo LaTorre C, Rivera González A, Rodríguez Vélez JG, Fonseca Ferrer V, Méndez Meléndez OF, Vázquez Vargas EJ, González Monroig HA. Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature. Am J Case Rep. 2019 Jan 21;20:83-90.
  5. Patrick C, Ward B, Anderson J, Rogers Keene K, Adams E, Cash RE, Panchal AR, Dickson R. Feasibility, Effectiveness and Safety of Prehospital Intravenous Bolus Dose Nitroglycerin in Patients with Acute Pulmonary Edema. Prehosp Emerg Care. 2020 Nov-Dec;24(6):844-850.
  6. Rydén L, Schaffrath R. Buccal versus sublingual nitroglycerin administration in the treatment of angina pectoris: a multicentre study. Eur Heart J. 1987 Sep;8(9):995-1001.
  7. Johansson SR, Ekström L, Emanuelsson H. Buccal nitroglycerin decreases ischemic pain during coronary angioplasty: a double-blind, randomized, placebo-controlled study. Am Heart J. 1990 Aug;120(2):275-81.
  8. Johansson SR, Ekström L, Emanuelsson H. Buccal nitroglycerin decreases ischemic pain during coronary angioplasty: a double-blind, randomized, placebo-controlled study. Am Heart J. 1990 Aug;120(2):275-81.
  9. Rydén L, Schaffrath R. Buccal versus sublingual nitroglycerin administration in the treatment of angina pectoris: a multicentre study. Eur Heart J. 1987 Sep;8(9):995-1001.
  10. Buccal and topical nitroglycerin. Lancet. 1987 Apr 25;1(8539):977-8.
  11. Sanghera SS, Goldberg AA, Parsons DG. Buccal nitroglycerin in elderly patients with congestive cardiac failure. Practitioner. 1985 Dec;229(1410):1054-5.
  12. Abrams J. Pharmacology of nitroglycerin and long-acting nitrates. Am J Cardiol. 1985 Jul 10;56(2):12A-18A.
  13. Nyberg G. Onset time of action and duration up to 3 hours of nitroglycerin in buccal, sublingual and transdermal form. Eur Heart J. 1986 Aug;7(8):673-8.
  14. Bogaert MG, Rosseel MT. Plasma levels in man of nitroglycerin after buccal administration. J Pharm Pharmacol. 1972 Sep;24(9):737-8
  15. Langbehn AF, Sheikhzadeh A, Stierle U, Thoran P. Effect of buccal nitroglycerin on pulmonary artery pressure at rest and during exercise: a comparison with sublingual nitroglycerin in patients with coronary artery disease. Z Kardiol. 1983;72 Suppl 3:239-45
  16. Opasich C, Riccardi G, Febo O, Tramarin R, Lepore AM, Luca C, Cobelli F, Specchia G. Resting and exertional haemodynamic effects of buccal nitroglycerin: acute and chronic discontinuous treatment in post-myocardial infarction patients with heart failure. Eur Heart J. 1988 Mar;9(3):252-8
  17. Cohn JN. Nitrates for congestive heart failure. Am J Cardiol. 1985 Jul 10;56(2):19A-23A. doi: 10.1016/0002-9149(85)91201-9.
  18. Shah PK. Buccal nitroglycerin ointment in acute cardiopulmonary edema. Ann Intern Med. 1985 Jul;103(1):153-4.
  19. Charuzi Y. Use of nitroglycerin ointment in acute pulmonary edema and hypertension. Chest. 1982 Dec;82(6):800
  20. Lahiri A, Crawley JC, Sonecha TN, Raftery EB. Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure. Int J Cardiol. 1984 Jan;5(1):39-48.
Table 1: Patients characteristics: BP=blood pressure, BT=before treatment, AT=after treatment, O2 sat=O2 saturation, APE=acute pulmonary edema